Virtual Empowered Relief for Chronic Pain
Virtual Empowered Relief for People With Chronic Pain Who Take Methadone or Buprenorphine
1 other identifier
interventional
73
1 country
1
Brief Summary
The purpose of the current pilot study is to examine a feasibility and the preliminary efficacy of Empowered Relief (ER) class when it is delivered 'virtually' to patients with chronic pain who take methadone or buprenorphine. The ER class is a single-session pain management class, which has demonstrated to be effective in improving pain and pain-related distress in patients with chronic low back pain, but its efficacy has not been examined in patients with chronic pain who take methadone or buprenorphine. Class participants will learn self-regulatory skills and develop a personalized plan to use the skills every day. The current study will examine a feasibility and participant's perception and satisfaction of this class at post-class. The study will also follow participants 3 months by administering 5 surveys (baseline, 2 weeks and 1 month, 2 months, and 3 months post-treatment) to determine whether the class confers the short-term and medium-term benefits across various aspects of health.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-pain
Started Sep 2021
Typical duration for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2021
CompletedStudy Start
First participant enrolled
September 8, 2021
CompletedFirst Posted
Study publicly available on registry
September 27, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2024
CompletedResults Posted
Study results publicly available
April 16, 2025
CompletedApril 16, 2025
March 1, 2025
2.1 years
September 8, 2021
January 29, 2025
March 27, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Perceived Usefulness
How useful was the information presented in the class? (a single item, 0-10 scale, higher scores correspond to greater perceived usefulness).
once immediately after class
Participant Satisfaction
Please rate your overall satisfaction with the class (a Single Item, 0-10 Scale, higher scores correspond to greater satisfaction).
once immediately after class
Likelihood of Using the Skills
How likely are you to use the skills and information you learned? (a Single Item, 0-10 Scale, higher scores correspond to greater likelihood)
once immediately after class
Secondary Outcomes (4)
Pain Bothersomeness
At 1 month post-tx
PCS Total Scores
At 1 month post-tx
Pain Intensity
At 1 month post-tx
PROMIS-Sleep Disturbance
At 1 month post-tx
Other Outcomes (6)
PROMIS-Pain Interference
At 1 month post-tx
PROMIS-Depression
At 1 month post-tx
PROMIS-Anxiety
At 1 month post-tx
- +3 more other outcomes
Study Arms (1)
Empowered Relief
EXPERIMENTALInterventions
The participants will attend the Empowered Relief class online via Zoom. The class includes pain neuroscience education, as well as cognition, emotion, and physiologic self-regulation for people with chronic pain. Class participants will learn self-management skills and develop a personalized plan to use the skills every day. Participants will receive an audio file (Relaxation Response) post-class. The class provides patients rapid access to actionable skills for symptom management and pain relief.
Eligibility Criteria
You may qualify if:
- Age at least 18 years old
- Chronic Pain (\> 3 months)
- Taking Methadone or Buprenorphine
- English Fluency
You may not qualify if:
- Pregnant,
- Gross Cognitive Impairment,
- Acute Suicidality,
- Severe Depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Pain Relief Innovations Lab
Palo Alto, California, 27604, United States
Related Publications (4)
Darnall BD, Roy A, Chen AL, Ziadni MS, Keane RT, You DS, Slater K, Poupore-King H, Mackey I, Kao MC, Cook KF, Lorig K, Zhang D, Hong J, Tian L, Mackey SC. Comparison of a Single-Session Pain Management Skills Intervention With a Single-Session Health Education Intervention and 8 Sessions of Cognitive Behavioral Therapy in Adults With Chronic Low Back Pain: A Randomized Clinical Trial. JAMA Netw Open. 2021 Aug 2;4(8):e2113401. doi: 10.1001/jamanetworkopen.2021.13401. Erratum In: JAMA Netw Open. 2022 Apr 1;5(4):e229739. doi: 10.1001/jamanetworkopen.2022.9739.
PMID: 34398206BACKGROUNDDarnall BD, Sturgeon JA, Kao MC, Hah JM, Mackey SC. From Catastrophizing to Recovery: a pilot study of a single-session treatment for pain catastrophizing. J Pain Res. 2014 Apr 25;7:219-26. doi: 10.2147/JPR.S62329. eCollection 2014.
PMID: 24851056BACKGROUNDZiadni MS, Anderson SR, Gonzalez-Castro L, Darnall BD. Comparative efficacy of a single-session "Empowered Relief" videoconference-delivered group intervention for chronic pain: study protocol for a randomized controlled trial. Trials. 2021 May 22;22(1):358. doi: 10.1186/s13063-021-05303-8.
PMID: 34022930BACKGROUNDKlein MR, Darnall BD, You DS. Feasibility of Web-Based Single-Session Empowered Relief in Patients With Chronic Pain Taking Methadone or Buprenorphine: Protocol for a Single-Arm Trial. JMIR Res Protoc. 2024 Jun 6;13:e53784. doi: 10.2196/53784.
PMID: 38843513BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Dokyoung Sophia You
- Organization
- Stanford University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 8, 2021
First Posted
September 27, 2021
Study Start
September 8, 2021
Primary Completion
October 23, 2023
Study Completion
February 2, 2024
Last Updated
April 16, 2025
Results First Posted
April 16, 2025
Record last verified: 2025-03